34 Headache Medicine, v.2, n.1, p.33-35, jan./feb./marc. 2011
LEITE EM, MARTINS HA, VALENÇA MM
through the CAPES periodics, accessing the most relevant
studies regarding to this association. The scrutiny used in
this review developed a methodological assessment as
follows:1– to observe the number of patients involved in
each of the studies; 2 – to analyze the method of allodynia
detection ; 3 – to describe the skin areas put to test; 4 – to
analyze the gender distribution of patients for each study;
5 – to describe the type of cluster headache (episodic or
chronic) in each study; 6 – to describe the mean duration
of disease; 7 – to analyze the prevalence results.
REVIEW
This primary headache also might be divided in two
major subtypes: episodic CH and chronic CH. The criteria
for this separation are well established, and when the
attacks occur for more than one year without remission,
or with remissions that last less than 14 days, then it fulfills
the features for the chronic form. Otherwise, when the
remissions last 14 days or more, and the attacks last seven
days to one year, it is defined as the episodic form.
(1)
In addition to these major subtypes, there is another
subdivision applied to the chronic cluster headache, which
defines the ones having a temporal pattern typical of
chronic forms since the onset as chronic CH unremitting
form. And the others that evolve from an initial episodic
pattern into the chronic features are named secondary
chronic forms. There is also the CH which has a chronic
pattern by the onset, and then evolves into an episodic
one, namely secondary episodic pattern, even though it
is the rarest form, it seems relevant to mention.
(4)
Concerning to the clinical characteristics of this primary
headache, it is imperative to mention that unlikely most
headaches, CH are far more common in males. There
are studies form 1979 and 1982 describing a ratio of 5
to 1, and even 9 to 1 men to female.
(5,6)
In more recent
works the authors describe a decline in this male to female
preponderance, with ratios of 2.4:1 and 3.2:1 male to
female in chronic CH in episodic forms and chronic CH
in unremitting forms, respectively.
(7)
Regarding to treatment, it is also necessary to
fractionate into abortive and prophylactic treatment. In
acute situations the abortive methods encompass the
oxygen inhalation at 100%, the use of subcutaneous
sumatriptan, dihydroergotamine in injectable and
intranasal forms, intranasal lydocaine, and as a resource
for oral treatment it has been mentioned the zolmitriptan.
The prophylaxis commonly involves verapamil as the main
alternative, and other drugs as lithium carbonate,
methysergide, valproic acid, topiramate, melatonin,
capsaicin, indometacin, prednisone, gabapentin and
some antipsychothic drugs, namely olanzapin and
clorpromazin. Other studies, small and open-labled ones,
mention methylphenidatem tizanidine, histamine,
somatostatin and pizotifen.
(4)
It is worth to point out, related to therapeutics, a case
of a 32 years old pregnant woman, who suffered from
CH, and whose response to oxygen treatment was none,
who had a relief with intranasal lydocaine. As lydocaine
has minimal risk for the pregnant woman and fetus, due
to its low toxicity, it may be useful as a primary step in
acute treatment for CH pregnant patients.
(8)
And there is
also a case report describing remission of refractory chronic
CH after warfarin administration.
(9)
RELATIONS AMONG ALLODYNIA AND
CLUSTER HEADACHE
Regarding to the number of patients involved in each
of the main studies, accessing the association between
allodynia and CH, it is remarkable that there is no study
with a great number of patients. It is understandable when
one considers the low prevalence of cluster headache in
general population, affecting 0.01% to 0.9% of general
population, and representing 8% to 10% of headache
patients.
(10,11)
The number of patients with CH tested for
allodynia in all studies analyzed vary from as few as two
(12)
to as much as 41.
(3)
Considering the method of allodynia detection, one
study used a pin prick testing in two patients.
(12)
Another
study by Ashkenazi et al. used a test for brush allodynia
(BA) in ten male patients, which was performed using a
4 x 4 - inch gauze pad, applied repetitively at a rate of
two per second, to six skin areas bilaterally in trigeminal
and cervical distributions [frontal (V1), maxillary (V2),
mandibular (V3), posterior neck (C2,C3), shoulder (C5),
and inner forearm(C8)].
(13)
Ladda et al. used a
quantitative sensory test performed in 16 CH patients
and ten healthy ones. This method aimed to determine
the subjects perception and pain thresholds for thermal
(use of thermode) and mechanical (vibrations, pressure
pain thresholds, pin prick, von Frey hairs) stimuli.
(14)
Marmura et al. also used the same test for BA described
above.
(3)
The skin areas put to test by Ladda et al. were the
right and left cheeks and the back of right and left
hands.
(14)
Marmura et al., nevertheless, tested the forehead
(V1), posterior neck (C2/C3) and inner forearm (C8) on